Women’s health biotech ObsEva has set the terms for an IPO that could net it in the region of $87 million.

President-elect Trump’s pick for HHS secretary bought shares in Zimmer Biomet, then introduced a bill that would have directly helped the company.

AstraZeneca has pushed back the estimated completion date for the phase 3 trial of its PD-L1 drug, a first-line treatment for non-small cell lung cancer.

Alcobra took a body blow last year when the FDA placed a clinical hold on its lead drug metadoxine, but a failed phase 3 trial has now delivered a coup de…

Evotec and MaRS Innovation have joined forces to found Fibrocor Therapeutics, a fibrotic disease startup.

Researchers led by Princeton have found a clue that could lead to a targeted treatment for Hepatitis E, a liver virus that causes 20 million infections a year.

The J.P. Morgan event is known as the event for biotech and the investor community and, although typically aimed at generalists, bio journalists are always on…

As his inauguration nears, Donald Trump has interviewed an eclectic mix of candidates for his pick as National Institutes of Health (NIH) chief.

Philips revealed Thursday that it is developing a new surgical system that uses augmented reality to guide surgeons performing open and minimally invasive…